The Redose Trap That Defines It
Gamma-hydroxybutyrate — GHB — is the substance where the standard harm reduction advice "start low, go slow" ceases to be a suggestion and becomes the entire safety strategy. The difference between the dose that produces euphoria and disinhibition and the dose that produces unconsciousness is measured in single milliliters — as little as one to two mL of liquid, or one capful. Worse, the window between them narrows as the night goes on: GHB's effects come on fast, tempt redosing, and stack on a delay, so the second dose arrives before the first has fully expressed. The predictable result is one of the most characteristic emergencies in recreational toxicology: a person who was dancing twenty minutes ago, now deeply unconscious, with a respiratory depression that can kill. Understanding GHB means understanding this pharmacology first, because virtually everything dangerous about it flows from one fact — the therapeutic window is narrow, and the user's own judgment of where they stand in it is the first thing the drug takes offline.
What GHB Is and Why It Exists
GHB is a naturally occurring compound in the human brain, where it acts as a neurotransmitter and metabolite of GABA, the brain's primary inhibitory system. Exogenous GHB floods that system: euphoria, disinhibition, increased sociability and libido, and at higher doses, heavy sedation. It has a legitimate medical identity — it's prescribed (as sodium oxybate, Xyrem) for narcolepsy with cataplexy, one of the most tightly controlled prescriptions in medicine — and a long shadow as a club drug ("liquid G," "G"), a date-rape drug (its involvement in drug-facilitated assault is documented and real, which is why it's among the most legally demonized substances), and a bodybuilding subculture relic from its 1990s growth-hormone-marketing era.
The pharmacology explains the danger completely. GHB is absorbed fast (15–30 minutes), peaks quickly, and clears in roughly one to two hours — a short, intense arc that invites redosing. Tolerance develops with heavy use. And the sedation it produces at overdose is respiratory depression mediated through the GABA-B receptor: breathing slows, the airway relaxes, vomiting aspiration becomes possible. Combine it with alcohol — its most common and most lethal partner — and the respiratory depression multiplies into the classic GHB death: someone who took G, had drinks, went to sleep, and never woke up.
The Dependence Profile Nobody Expects
GHB carries one of the most severe withdrawal syndromes in the entire pharmacopoeia, and it's nearly unknown outside addiction medicine: heavy daily users — a real population, concentrated in certain club scenes where daily G use is normalized — who stop abruptly can progress within hours to a withdrawal featuring severe agitation, delirium, psychosis, autonomic instability, and seizures. GHB withdrawal is a genuine medical emergency requiring hospital-level management, frequently with intensive care. This is not the "irritable week" of cannabis cessation; it sits closer to alcohol and benzodiazepine withdrawal on the lethality scale. Anyone using GHB daily, or approaching daily, needs to understand that stopping suddenly — the bag runs out, the weekend ends, the resolution arrives — can hospitalize them, and that medical tapering is the safe route.
The Date-Rape Dimension
GHB's role in drug-facilitated sexual assault deserves direct treatment, because the harm reduction frame applies to potential victims as much as users. GHB is colorless, mostly tasteless (slightly salty, easily masked), and dissolves instantly — and at incapacitating doses it produces what witnesses describe as a switch flipping: coherent one moment, deeply unconscious the next, with anterograde amnesia on waking. Protections: never leave drinks unattended; treat sudden, disproportionate intoxication in yourself or a friend — one drink feeling like five, sudden dizziness or confusion out of proportion — as a medical emergency, not embarrassment; watch friends' drinks, not just your own; and know that most jurisdictions have evidence-collection protocols usable even when memory is missing. This is not paranoia; it's the documented pattern of the drug.
Harm Reduction Essentials
For anyone who uses GHB despite the risk profile, the distilled guidance from toxicology and the club-health community:
Measure, never free-pour. The difference between a dose and an overdose is one mL. Use a measured syringe or marked bottle cap; treat any source that can't tell you the concentration with extreme suspicion, because liquid GHB's strength varies enormously.
Never redose inside 90 minutes — and ideally not inside two hours. The stacking trap is the single most common overdose mechanism.
Never combine with alcohol or other depressants — opioids, benzodiazepines, sleep aids, antihistamines. This is the fatal combination, full stop.
Never use alone. The unconsciousness is silent and fast; an alone user who misjudges has no margin.
If someone is unrousable on GHB: call emergency services immediately; place them in the recovery position to protect the airway; never induce vomiting; be honest with paramedics — naloxone doesn't reverse GHB, and they need to know what they're treating. Stay until help arrives.
If you use daily: do not stop suddenly. Medical supervision and tapering are the safe path, and GHB withdrawal is not something to white-knuckle.
GHB sits at the extreme of a pattern this series returns to again and again: the molecule's dangers are not exotic but pharmacological, knowable, and concentrated in a few specific behaviors. With GHB those behaviors — redosing, mixing with alcohol, using alone, abrupt cessation — are the difference between a scene drug with manageable risks and a coroner's report. The knife-edge is real. So is the ability to respect it.
The Community That Grew Around It
GHB's modern harm reduction story is inseparable from the club communities that built informal safety cultures around it in the 2000s — communities where measured dosing, designated sitters, and the cardinal rules (no alcohol, no redosing inside ninety minutes, never alone) were passed between users with a rigor the wider drug world rarely matched. That culture developed for a reason: GHB punished its rule-breakers more reliably and more finally than almost any scene drug, and the community's elders were the survivors of its lessons. The modern reader encountering GHB through dating-app markets, festival strangers, or "GHB-adjacent" products like the prodrug GBL (which converts to GHB in the body and carries the identical risk profile with worse dosing unpredictability) inherits none of that accumulated culture — and inherits all of the risk. The gap between the informed scene veteran with a marked syringe and the first-time user handed a capful by a stranger is the entire story of GHB harm, and closing that gap — with measurement, with the redose rule, with the alcohol prohibition stated absolutely — is what any honest account owes.
The Bottom Line (Revisited)
GHB sits at the extreme of a pattern this series returns to again and again: the molecule's dangers are not exotic but pharmacological, knowable, and concentrated in a few specific behaviors. With GHB those behaviors — redosing, mixing with alcohol, using alone, abrupt cessation after daily use — are the difference between a scene drug with manageable risks and a coroner's report. The knife-edge is real. So is the ability to respect it: measure every dose, wait ninety minutes, ban alcohol absolutely, never use alone, and treat daily use as a medical situation requiring a supervised taper rather than a willpower challenge. Nothing about GHB rewards improvisation. Everything about it rewards discipline.
